Literature DB >> 12950343

Laminin, hyaluronan, tenascin-C and type VI collagen levels in sera from patients with malignant melanoma.

E R Burchardt1, R Hein, A K Bosserhoff.   

Abstract

In this study, hyaluronan, laminin-1, tenascin-C and type VI collagen were measured in the sera of patients with stage I/II and stage IV melanoma. A significant increase in the serum levels of all four extracellular matrix proteins was found in patients with stage IV melanoma compared to healthy donors. Type VI collagen and hyaluronan serum levels were also significantly increased in stage I/II melanoma. Increased expression of the four matrix proteins was also demonstrated in melanoma cell lines using reverse transcriptase- polmerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). We suggest that tenascin-C, hyaluronan, laminin-1 and type VI collagen are involved in melanoma development and extracellular matrix remodelling during melanoma progression. This finding will be of interest in the development of serum markers for progression of malignant melanoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12950343     DOI: 10.1046/j.1365-2230.2003.01326.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  15 in total

1.  Serum laminin is an independent prognostic factor in colorectal cancer.

Authors:  Noboru Saito; Shingo Kameoka
Journal:  Int J Colorectal Dis       Date:  2004-12-08       Impact factor: 2.571

2.  cDNA microarray analysis of cancer associated gene expression profiles in malignant peripheral nerve sheath tumours.

Authors:  K Karube; K Nabeshima; M Ishiguro; M Harada; H Iwasaki
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

Review 3.  Tenascin-C Signaling in melanoma.

Authors:  Hanshuang Shao; John M Kirkwood; Alan Wells
Journal:  Cell Adh Migr       Date:  2015       Impact factor: 3.405

Review 4.  Is there a place for serum laminin determination in patients with liver disease and cancer?

Authors:  Heitor Rosa; Edison Roberto Parise
Journal:  World J Gastroenterol       Date:  2008-06-21       Impact factor: 5.742

5.  B and C domain containing tenascin-C: urinary markers for invasiveness of urothelial carcinoma of the urinary bladder?

Authors:  Petra Richter; Markus Tost; Marcus Franz; Annelore Altendorf-Hofmann; Kerstin Junker; Laura Borsi; Dario Neri; Hartwig Kosmehl; Heiko Wunderlich; Alexander Berndt
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-27       Impact factor: 4.553

6.  Clinical significance of serum laminin and type-IV collagen levels in cutaneous melanoma patients.

Authors:  Faruk Tas; Elif Bilgin; Senem Karabulut; Derya Duranyildiz
Journal:  Mol Clin Oncol       Date:  2016-04-25

7.  Clinical significance of serum tenascin-c levels in epithelial ovarian cancer.

Authors:  Tastekin Didem; Tas Faruk; Karabulut Senem; Duranyildiz Derya; Serilmez Murat; Guveli Murat; Kaynur Oznur
Journal:  Tumour Biol       Date:  2014-04-11

8.  Clinical significance of serum tenascin-C levels in breast cancer.

Authors:  D Tastekin; F Tas; S Karabulut; D Duranyildiz; M Serilmez; M Guveli; S Vatansever
Journal:  Tumour Biol       Date:  2014-04-03

9.  Naturally produced extracellular matrix inhibits growth rate and invasiveness of human osteosarcoma cancer cells.

Authors:  V Ivanov; S Ivanova; M W Roomi; T Kalinovsky; A Niedzwiecki; M Rath
Journal:  Med Oncol       Date:  2007       Impact factor: 3.064

10.  Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention.

Authors:  Doris M Benbrook; Stan Lightfoot; James Ranger-Moore; Tongzu Liu; Shylet Chengedza; William L Berry; Igor Dozmorov
Journal:  Gene Regul Syst Bio       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.